Taysha Gene Therapies Inc (TSHA)
2.525
+0.14
(+6.09%)
USD |
NASDAQ |
May 09, 16:00
2.525
0.00 (0.00%)
After-Hours: 20:00
Taysha Gene Therapies 1 Year Total Returns (Daily): 235.2% for May 8, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 08, 2024 | 235.2% |
| May 07, 2024 | 251.4% |
| May 06, 2024 | 271.2% |
| May 03, 2024 | 280.8% |
| May 02, 2024 | 253.5% |
| May 01, 2024 | 240.8% |
| April 30, 2024 | 213.5% |
| April 29, 2024 | 216.1% |
| April 26, 2024 | 264.0% |
| April 25, 2024 | 260.8% |
| April 24, 2024 | 253.0% |
| April 23, 2024 | 257.9% |
| April 22, 2024 | 247.9% |
| April 19, 2024 | 198.7% |
| April 18, 2024 | 210.2% |
| April 17, 2024 | 199.5% |
| April 16, 2024 | 196.1% |
| April 15, 2024 | 205.9% |
| April 12, 2024 | 335.2% |
| April 11, 2024 | 372.8% |
| April 10, 2024 | 372.2% |
| April 09, 2024 | 341.8% |
| April 08, 2024 | 300.0% |
| April 05, 2024 | 288.4% |
| April 04, 2024 | 278.0% |
| Date | Value |
|---|---|
| April 03, 2024 | 253.2% |
| April 02, 2024 | 239.8% |
| April 01, 2024 | 256.1% |
| March 28, 2024 | 340.2% |
| March 27, 2024 | 356.1% |
| March 26, 2024 | 350.0% |
| March 25, 2024 | 350.0% |
| March 22, 2024 | 345.8% |
| March 21, 2024 | 308.1% |
| March 20, 2024 | 314.6% |
| March 19, 2024 | 220.5% |
| March 18, 2024 | 203.4% |
| March 15, 2024 | 161.9% |
| March 14, 2024 | 136.1% |
| March 13, 2024 | 139.6% |
| March 12, 2024 | 145.7% |
| March 11, 2024 | 155.6% |
| March 08, 2024 | 140.0% |
| March 07, 2024 | 142.3% |
| March 06, 2024 | 165.7% |
| March 05, 2024 | 159.3% |
| March 04, 2024 | 177.8% |
| March 01, 2024 | 210.6% |
| February 29, 2024 | 212.9% |
| February 28, 2024 | 161.4% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.12%
Minimum
Oct 19 2022
372.8%
Maximum
Apr 11 2024
-32.52%
Average
-75.25%
Median
Jun 20 2023
1 Year Total Returns (Daily) Benchmarks
| Aquestive Therapeutics Inc | 37.11% |
| Lifecore Biomedical Inc | 48.77% |
| Relmada Therapeutics Inc | 8.19% |
| ACADIA Pharmaceuticals Inc | -20.51% |
| Cyclacel Pharmaceuticals Inc | -71.80% |